Skip to main content
. 2018 Jul 9;53(3):1043–1054. doi: 10.3892/ijo.2018.4477

Figure 1.

Figure 1

Effects of NT21MP on the expression level of miR-155-3p/5p in MCF-7 and MCF-7/PR cell lines. (A) Effects of NT21MP on the expression level of miR-155-3p in MCF-7 and MCF-7/PR cells, detected using RT-qPCR analysis, compared with control groups. (B) Effects of NT21MP on the expression level of miR-155-5p in MCF-7 and MCF-7/PR cells, detected using RT-qPCR analysis, compared with control groups. **P<0.01, ***P<0.001, ##P<0.01 and ###P<0.001, compared with SDF-1α treatment. NT21MP; 21-residue peptide derived from viral macrophage inflammatory protein II; miR, microRNA; SDF-1α, stromal cell-derived factor-1α; PR, paclitaxel-resistant; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.